Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0420
+0.0010 (2.44%)
At close: Jan 16, 2026
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $3.12 million as of January 16, 2026. Its market cap has decreased by -53.54% in one year.
Market Cap
3.12M
Enterprise Value
3.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 3.12M, a decrease of -97.12%. That is a compound annual growth rate of -9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.12M | 10.82% |
| Dec 31, 2025 | 2.81M | -75.72% |
| Dec 31, 2024 | 11.58M | 66.86% |
| Dec 29, 2023 | 6.94M | -62.07% |
| Dec 30, 2022 | 18.31M | -27.99% |
| Dec 31, 2021 | 25.42M | 37.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 446.47M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 262.62M |